Literature DB >> 21048908

Adjuvant Systemic Therapy, Quo Vadis? Patient Selection, Prognostic and Predictive Factors.

Fatima Cardoso1.   

Abstract

Entities:  

Year:  2008        PMID： 21048908      PMCID： PMC2931025          DOI： 10.1159/000176533

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  18 in total

1.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

2.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 3.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Authors:  Lyndsay Harris; Herbert Fritsche; Robert Mennel; Larry Norton; Peter Ravdin; Sheila Taube; Mark R Somerfield; Daniel F Hayes; Robert C Bast
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

4.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

5.  Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Authors:  Giuseppe Viale; Meredith M Regan; Mauro G Mastropasqua; Fausto Maffini; Eugenio Maiorano; Marco Colleoni; Karen N Price; Rastko Golouh; Tiziana Perin; R W Brown; Anikó Kovács; Komala Pillay; Christian Ohlschlegel; Barry A Gusterson; Monica Castiglione-Gertsch; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  J Natl Cancer Inst       Date:  2008-01-29       Impact factor: 13.506

6.  Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.

Authors:  N Harbeck; P Dettmar; C Thomssen; U Berger; K Ulm; R Kates; H Höfler; F Jänicke; H Graeff; M Schmitt
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

Review 7.  Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Authors:  Stella Mook; Laura J Van't Veer; Emiel J T Rutgers; Martine J Piccart-Gebhart; Fatima Cardoso
Journal:  Cancer Genomics Proteomics       Date:  2007 May-Jun       Impact factor: 4.069

8.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

9.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

10.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

Authors:  E de Azambuja; F Cardoso; G de Castro; M Colozza; M S Mano; V Durbecq; C Sotiriou; D Larsimont; M J Piccart-Gebhart; M Paesmans
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.